Article: Other News To Note.

Acadia Pharmaceuticals Inc., of San Diego, reported at the Chemical Genomics Session of the National Medicinal Chemistry Symposium in San Diego the successful application of its chemical-genomics approach to more than 100 G protein-coupled receptor and nuclear receptor targets. Acadia said its discovery efforts to date have resulted in the identification of small-molecule ligands for more than 60 such targets, including agonists for several targets previously believed to be non-druggable.

Affymetrix Inc., of Santa Clara, Calif., entered a multiyear EasyAccess Silver agreement with NV Organon, of Oss, the Netherlands, under which Organon will gain access to ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!